SmallCapPower | February 2016 Roger Dumoulin-White, CEO of Theralase Technologies Inc. (TSXV: TLT), stopped to speak with SmallCapPower at the recent AlphaNorth Capital Conference, explaining how Theralase’s medical devices can both heal tissue and well as destroy cancer cells. Its laser recently received FDA approval and the Company’s revenue has been ramping up over the past three years with a big surge expected in 2016.
